Skip to content

Preemptive Analgesia in Cruciate Reconstruction

Comparing Etoricoxib and Celecoxib for Preemptive Analgesia for Acute Postoperative Pain in Patients Undergoing Arthroscopic Anterior Cruciate Ligament Reconstruction: A Randomized Controlled Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01017380
Enrollment
30
Registered
2009-11-20
Start date
2008-01-31
Completion date
2009-06-30
Last updated
2009-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Cruciate Ligament Injury

Keywords

preemptive analgesia, cruciate ligament

Brief summary

The aims of this study was to compare analgesic efficacy of preoperative administration of etoricoxib versus celecoxib for post-operative pain relief after arthroscopic anterior cruciate ligament reconstruction. One hundred and two patients diagnosed as anterior cruciate ligament injury will randomized into 3 groups using opaque envelope. Both patients and surgeon were blinded to the allocation. All of the patients will be operated by one orthopaedic surgeon under regional anesthesia. Each group will be given either etoricoxib 120 mg., celecoxib 400 mg., or placebo 1 hour prior to operative incision. Post-operative pain intensity, time to first dose of analgesic requirement and numbers of analgesic used for rescue pain control and adverse events will be recorded periodically to 48 hours after surgery.

Interventions

DRUGCelecoxib

celecoxib 400 mg 1 cap before surgery

DRUGetoricoxib

120 mg 1 tab before surgery

Sponsors

Prince of Songkla University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
15 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* patients with anterior cruciate ligament injury age 15-50 yr

Exclusion criteria

* previous knee surgery

Design outcomes

Primary

MeasureTime frame
VAS score6,12,24,48 hour postoperative

Secondary

MeasureTime frame
number of analgesic used48 hour postoperative

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 30, 2026